Browsing by Keyword : Immune Checkpoint Inhibitors
Showing results 1 to 11 of 11
| Pub Year | | Title | AJOU Author(s) |
| 2022 | | A phase IA dose-escalation study of PHI-101, a new checkpoint kinase 2 inhibitor, for platinum-resistant recurrent ovarian cancer | 공태욱, 장석준 |
| 2022 | | Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer | 김석휘 |
| 2024 | | Clinical Validation of Artificial Intelligence-Powered PD-L1 Tumor Proportion Score Interpretation for Immune Checkpoint Inhibitor Response Prediction in Non-Small Cell Lung Cancer | 김석휘 |
| 2020 | | Current Perspectives on (89)Zr-PET Imaging | 박복남, 안영실, 윤준기, 이수진 |
| 2024 | | Immune checkpoint inhibitor monotherapy is sufficient to promote microenvironmental normalization via the type I interferon pathway in PD-L1-expressing head and neck cancer | 김철호, 신유섭, 우현구, 이복순, 장전엽, 최지혜 |
| 2023 | | Immune profiles according to EGFR mutant subtypes and correlation with PD-1/PD-L1 inhibitor therapies in lung adenocarcinoma | 고영화, 박범희, 이현우, 한재호, 함석진 |
| 2024 | | Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types | 김석휘 |
| 2024 | | Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer | 공태욱, 손주혁 |
| 2023 | | Molecular and Immune Profiling of Syngeneic Mouse Models Predict Response to Immune Checkpoint Inhibitors in Gastric Cancer | 한상욱, 함인혜, 허훈 |
| 2024 | | Prediction of Responsiveness to PD-L1/PD-1 Inhibitors Using miRNA Profiles Associated With PD-L1 Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma | 고영화, 이현우, 한재호, 함석진 |
| 2021 | | Therapeutic efficacy of cancer vaccine adjuvanted with nanoemulsion loaded with TLR7/8 agonist in lung cancer model | 양시영 |
1
